At Quilam, we invest and lend into businesses in the speciality finance sector, where we provide expert and bespoke capital solutions. We believe that flexibility of funding is everything, and hence we offer both debt and equity products.
We provide £5-£200m+ committed term funding, to enable businesses to reach their full potential, but not simply through capital deployment; our advisory approach uses our industry experience and insight to challenge management teams on all aspects of their business.
We provide £5-£200m+ of committed investment capital
We provide core balance sheet funding to facilitate growth
We provide working capital where needed and will make acquisitions or facilitate MBO’s
We provide hands-on support to facilitate growth strategies for our clients
We combine the benefits of Private Equity, whilst management retain a greater control of the business
From operations and risk, through to strategic direction and development, we provide support at every stage of a company’s journey, injecting early stage and growth capital, arranging market leading senior terms, and facilitating an exit when the time is right.
About Quilam
Responsible Investing we strive to ensure that across our portfolio we are making a positive impact on people, society and the environment
£2.2bn senior and third party junior debt raised across the portfolio, spread across 21 different banks and credit funds
£460m of new capital raised in 2021, taking total funds available or under management to c.£600m
18 distinct sub sectors of the Speciality Finance market across the portfolio, covering a wide range of consumer and SME sectors and products.
We enjoy the challenge of developing a business from scratch. We share in our clients’ highs and lows, and take delight in seeing them thrive.
Read more
We provide bespoke capital structure solutions, expert advice, and partnership to clients in the speciality finance sector.
Read more
We have extensive knowledge and experience of deploying capital and building specialist lending platforms in the UK and Europe.
Read more